You are here

Article Text

Article menu
Download PDFPDF
palliativedrugs.com
Updates
  1. Andrew Wilcock1 and
  2. Sarah Charlesworth2
  1. 1 Department of Palliative Medicine, University of Nottingham, Nottingham, UK
  2. 2 palliativedrugs.com, Hayward House Study Centre, Nottingham University Hospitals, Nottingham, UK
  1. Correspondence to Sarah Charlesworth, Hayward House Study Centre, palliativedrugs.com, Nottingham, UK; s.charlesworth{at}nhs.net

https://doi.org/10.1136/bmjspcare-2017-001442

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The website www.palliativedrugs.com has provided essential independent information about drugs used in palliative and hospice care for over a decade and has over 30 000 members from 169 countries. It contains the online Palliative Care Formulary (PCF) and provides free access to a Bulletin board to stimulate questions and share experiences, a Document library containing 475 items of useful information and a Syringe Driver Survey Database containing details of over 2350 different drug combinations. The UK Palliative Care Formulary sixth edition (book and online version) and Introducing Palliative Care fifth edition can also be purchased via the website. This feature provides a selection of items that have featured in the News and Latest additions sections in recent months; for additional information, please register for free on the website.

    Safety updates

    Corticosteroids: rare risk of central serous chorioretinopathy

    The UK Medicines and Healthcare products Regulatory Agency (MHRA) has warned of a rare risk of central serous chorioretinopathy with local administration of corticosteroids, that is, inhaled, epidural, intra-articular, topical dermal and periocular routes, in addition to the known risk with the systemic use of corticosteroids. Patients should be advised to report any blurred vision or visual disturbances.

    Over-the-counter miconazole oral gel: contraindicated in patients on warfarin

    The MHRA has stated that patients taking warfarin should not use over-the-counter miconazole oral gel. This measure has been implemented following a review of reports of serious and fatal bleeding events in patients using topical miconazole while taking warfarin. If prescribers …

    View Full Text

    Footnotes

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; internally peer reviewed.